Carlsson Marcus, Ubachs Joey F A, Hedström Erik, Heiberg Einar, Jovinge Stefan, Arheden Håkan
Cardiac MR Group, Department of Clinical Physiology, Lund University Hospital, Lund, Sweden.
JACC Cardiovasc Imaging. 2009 May;2(5):569-76. doi: 10.1016/j.jcmg.2008.11.018.
Our goal was to validate myocardium at risk on T2-weighted short tau inversion recovery (T2-STIR) cardiac magnetic resonance (CMR) over time, compared with that seen with perfusion single-photon emission computed tomography (SPECT) in patients with ST-segment elevation myocardial infarction, and to assess the amount of salvaged myocardium after 1 week.
To assess reperfusion therapy, it is necessary to determine how much myocardium is salvaged by measuring the final infarct size in relation to the initial myocardium at risk of the left ventricle (LV).
Sixteen patients with first-time ST-segment elevation myocardial infarction received (99m)Tc tetrofosmin before primary percutaneous coronary intervention. SPECT was performed within 4 h and T2-STIR CMR within 1 day, 1 week, 6 weeks, and 6 months. At 1 week, patients were injected with a gadolinium-based contrast agent for quantification of infarct size.
Myocardium at risk at occlusion on SPECT was 33 +/- 10% of the LV. Myocardium at risk on T2-STIR did not differ from SPECT, at day 1 (29 +/- 7%, p = 0.49) or week 1 (31 +/- 6%, p = 0.16) but declined at week 6 (10 +/- 12%, p = 0.0096 vs. 1 week) and month 6 (4 +/- 11%, p = 0.0013 vs. 1 week). There was a correlation between myocardium at risk demonstrated by T2-STIR at week 1 and myocardium at risk by SPECT (r(2) = 0.70, p < 0.001), and the difference between the methods on Bland-Altman analysis was not significant (-2.3 +/- 5.7%, p = 0.16). Both modalities identified myocardium at risk in the same perfusion territory and in concordance with angiography. Final infarct size was 8 +/- 7%, and salvage was 75 +/- 19% of myocardium at risk.
This study demonstrates that T2-STIR performed up to 1 week after reperfusion can accurately determine myocardium at risk as it was before opening of the occluded artery. CMR can also quantify salvaged myocardium as myocardium at risk minus final infarct size.
我们的目标是,对于ST段抬高型心肌梗死患者,随着时间推移,验证在T2加权短反转时间反转恢复序列(T2-STIR)心脏磁共振成像(CMR)上的危险心肌,与灌注单光子发射计算机断层扫描(SPECT)所见进行比较,并评估1周后挽救心肌的量。
为了评估再灌注治疗,有必要通过测量最终梗死面积与左心室(LV)初始危险心肌的关系来确定挽救了多少心肌。
16例首次发生ST段抬高型心肌梗死的患者在接受直接经皮冠状动脉介入治疗前接受(99m)锝替曲膦。SPECT在4小时内进行,T2-STIR CMR在1天、1周、6周和6个月时进行。在1周时,给患者注射钆基造影剂以定量梗死面积。
SPECT显示闭塞时的危险心肌为LV的33±10%。T2-STIR显示的危险心肌在第1天(29±7%,p = 0.49)或第1周(31±6%,p = 0.16)与SPECT无差异,但在第6周(10±12%,与第1周相比p = 0.